{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:31:12Z","timestamp":1791405072202,"version":"4.3.3"},"reference-count":187,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00516","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:58:22Z","timestamp":1597107502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":119,"title":["Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions"],"prefix":"10.3389","volume":"11","author":[{"given":"Antonio","family":"Aversa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella E.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine."},{"key":"B2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"Van Hooff","year":"2004","journal-title":"Hum Reprod."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome Part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40200-018-0371-5","article-title":"Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach","volume":"17","author":"Toosy","year":"2018","journal-title":"J Diabetes Metab Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1210\/jc.82.12.4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9201701","DOI":"10.1155\/2016\/9201701","article-title":"The relationship between adiposity and insulin sensitivity in african women living with the polycystic ovarian syndrome: a clamp study","volume":"2016","author":"Doh","year":"2016","journal-title":"Int J Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/CS20130186","article-title":"Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition","volume":"126","author":"Sprung","year":"2014","journal-title":"Clin Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"ESE PCOS special interest group","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1097\/MED.0b013e328359ff92","article-title":"Reproductive impact of polycystic ovary syndrome","volume":"19","author":"Usadi","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril."},{"key":"B11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.23736\/S0026-4784.18.04230-2","article-title":"Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence","volume":"70","author":"Palomba","year":"2018","journal-title":"Minerva Ginecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"Br J Obstet Gynecol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/MED.0b013e3282f1d6cb","article-title":"Obesity and infertility","volume":"14","author":"Pasquali","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.fertnstert.2008.04.063","article-title":"Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome","volume":"92","author":"Jungheim","year":"2009","journal-title":"Fertil Steril."},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41367-019-0009-1","article-title":"Obesity programs of nutrition, education, research and assessment (OPERA) group","volume":"9","author":"Gambineri","year":"2019","journal-title":"Int J Obes Suppl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2174\/0929867325666171205144119","article-title":"Uterine function: from normal to polycystic ovarian syndrome alterations","volume":"25","author":"Ferreira","year":"2018","journal-title":"Curr Med Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism reivisted","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1210\/en.2019-00101","article-title":"Physiological and pathological androgen actions in the ovary","volume":"160","author":"Astapova","year":"2019","journal-title":"Endocrinology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00281-019-00737-4","article-title":"Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?","volume":"41","author":"Popovic","year":"2019","journal-title":"Semin Immunopathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0035-1556568","article-title":"The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome","volume":"33","author":"Shorakes","year":"2015","journal-title":"Semin Reprod Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low-grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci","year":"2011","journal-title":"Mol Cell Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.numecd.2009.01.007","article-title":"Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome","volume":"19","author":"Gambineri","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/BF03346757","article-title":"Glucose intolerance states in women with the polycystic ovary syndrome","volume":"36","author":"Pasquali","year":"2013","journal-title":"J Endocrinol Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jri.2015.09.072","article-title":"Association of TLR2 S450S and ICAM1 K469E polymorphisms with polycystic ovary syndrome (PCOS) and obesity","volume":"113","author":"Ojeda-Ojeda","year":"2016","journal-title":"J Reprod Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression","volume":"148","author":"Jager","year":"2007","journal-title":"Endocrinology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/IJPSYM.IJPSYM_561_17","article-title":"Anxiety, depression, and quality of life in women with polycystic ovarian syndrome","volume":"40","author":"Chaudhari","year":"2018","journal-title":"Indian J Psychol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0366-6999.198916","article-title":"Increased risk of psychiatric disorders in women with polycystic ovary syndrome in southwest China","volume":"130","author":"Tan","year":"2017","journal-title":"Chin Med J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/09513590.2016.1254610","article-title":"The evaluation of temperament and quality of life in patients with polycystic ovary syndrome","volume":"33","author":"Ozcan Dag","year":"2017","journal-title":"Gynecol Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/jog.12696","article-title":"Psychiatric comorbidity in women with polycystic ovary syndrome","volume":"41","author":"Annag\u00fcr","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/humrep\/der071","article-title":"Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?","volume":"26","author":"Deeks","year":"2011","journal-title":"Hum Reprod Oxf Engl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar","year":"2011","journal-title":"Hum Reprod."},{"key":"B36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fendo.2014.00185","article-title":"Personality and psychiatric disorders in women affected by polycystic ovary syndrome","volume":"5","author":"Scaruffi","year":"2014","journal-title":"Front Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpag.2019.07.008","article-title":"Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome","volume":"32","author":"\u00c7oban","year":"2019","journal-title":"J Pediatr Adolesc Gynecol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/09513590.2018.1427713","article-title":"Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome","volume":"34","author":"Stapinska-Syniec","year":"2018","journal-title":"Gynecol Endocrinol."},{"key":"B39","first-page":"92","article-title":"Comparing sexual function and quality of life in polycystic ovary syndrome and healthy women","volume":"10","author":"Shafti","year":"2016","journal-title":"J Fam Reprod Health."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1210\/clinem\/dgz256","article-title":"Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms","volume":"105","author":"Karjula","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijerph15020376","article-title":"Determinants of quality of life and satisfaction with life in women with polycystic ovary syndrome","volume":"15","author":"Rzonca","year":"2018","journal-title":"Int J Environ Res Public Health."},{"key":"B42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/PPA.S119180","article-title":"Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome","volume":"11","author":"Panico","year":"2017","journal-title":"Patient Prefer Adherence."},{"key":"B43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/cen.12783","article-title":"Psychological aspects of hyperandrogenic states in late adolescent and young women","volume":"83","author":"Guidi","year":"2015","journal-title":"Clin Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0162911","DOI":"10.1371\/journal.pone.0162911","article-title":"Comparison of the association of excess weight on health related quality of life of women with polycystic ovary syndrome: an age- and bmi-matched case control study","volume":"11","author":"Shishehgar","year":"2016","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/09513590600604541","article-title":"Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the polycystic ovary syndrome questionnaire (PCOSQ) and the short form-36 (SF-36)","volume":"22","author":"Coffey","year":"2006","journal-title":"Gynecol Endocrinol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2019.05.006","article-title":"Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome","volume":"253","author":"Kogure","year":"2019","journal-title":"J Affect Disord."},{"key":"B47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00404-019-05202-z","article-title":"Quality of life among infertile PCOS patients","volume":"300","author":"Angin","year":"2019","journal-title":"Arch Gynecol Obstet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12905-018-0658-1","article-title":"Polycystic ovary syndrome and its impact on Iranian women's quality of life: a population-based study","volume":"18","author":"Behboodi Moghadam","year":"2018","journal-title":"BMC Womens Health."},{"key":"B49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00404-014-3423-1","article-title":"The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome","volume":"291","author":"Benetti-Pinto","year":"2015","journal-title":"Arch Gynecol Obstet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jad.2015.06.043","article-title":"Evaluation of affective temperament and anxiety-depression levels of patients with polycystic ovary syndrome","volume":"185","author":"Asik","year":"2015","journal-title":"J Affect Disord."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin","volume":"93","author":"Harris-Glocker","year":"2010","journal-title":"Fertil Steril."},{"key":"B53","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.fertnstert.2016.12.014","article-title":"Increased risk of disordered eating in polycystic ovary syndrome","volume":"107","author":"Lee","year":"2017","journal-title":"Fertil Steril."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/jsm.12627","article-title":"Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS","volume":"11","author":"Hashemi","year":"2014","journal-title":"J Sex Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejogrb.2010.12.012","article-title":"Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls","volume":"155","author":"M\u00e5nsson","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1210\/jc.2003-030562","article-title":"Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome","volume":"88","author":"Elsenbruch","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ijir.2016.35","article-title":"Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study","volume":"29","author":"Noroozzadeh","year":"2017","journal-title":"Int J Impot Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.17772\/gp\/1995","article-title":"Sexuality in women with polycystic ovary syndrome","volume":"86","author":"Kowalczyk","year":"2015","journal-title":"Ginekol Pol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/0092623X.2013.864369","article-title":"Body composition characteristics predict sexual functioning in obese women with or without PCOS","volume":"41","author":"Zueff","year":"2015","journal-title":"J Sex Marital Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jsm.12011","article-title":"Changes in sexual function among women with polycystic ovary syndrome: a pilot study","volume":"10","author":"Ferraresi","year":"2013","journal-title":"J Sex Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ijir.2013.2","article-title":"Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome","volume":"25","author":"Ercan","year":"2013","journal-title":"Int J Impot Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1743-6109.2011.02539.x","article-title":"Sexual function in women with polycystic ovary syndrome","volume":"9","author":"Stovall","year":"2012","journal-title":"J Sex Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1111\/j.1743-6109.2008.01010.x","article-title":"PCOS, sexuality, and clitoral vascularisation: a pilot study","volume":"5","author":"Battaglia","year":"2008","journal-title":"J Sex Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"191.e1","DOI":"10.1016\/j.ajog.2017.04.034","article-title":"Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility","volume":"217","author":"Diamond","year":"2017","journal-title":"Am J Obstet Gynecol."},{"key":"B65","first-page":"539","article-title":"Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains","volume":"12","author":"Eftekhar","year":"2014","journal-title":"Iran J Reprod Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yhbeh.2012.10.013","article-title":"Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome","volume":"63","author":"Rellini","year":"2013","journal-title":"Horm Behav."},{"key":"B67","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/humrep\/deu342","article-title":"Sexual and relational satisfaction in couples where the woman has polycystic ovary syndrome: a dyadic analysis","volume":"30","author":"De Fr\u00e8ne","year":"2015","journal-title":"Hum Reprod Oxf Engl."},{"key":"B68","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2018-01787","article-title":"Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome","volume":"104","author":"Christ","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1008517","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"15","author":"Day","year":"2019","journal-title":"PLoS Genet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-19-0197","article-title":"Mechanisms of intergenerational transmission of polycystic ovary syndrome","volume":"159","author":"Dumesic","year":"2020","journal-title":"Reproduction."},{"key":"B72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/humupd\/dmx013","article-title":"Is foetal hyperexposure to androgens a cause of PCOS?","volume":"23","author":"Filippou","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"218598","DOI":"10.1155\/2011\/218598","article-title":"Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of \u201cmetabolic memory\u201d","volume":"2011","author":"Yessoufou","year":"2011","journal-title":"Exp Diabetes Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humupd\/dmz036","article-title":"Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis","volume":"26","author":"Gunning","year":"2020","journal-title":"Hum Reprod Update."},{"key":"B77","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Clinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/humrep\/dey087","article-title":"Maternal polycystic ovarian syndrome and early offspring development","volume":"33","author":"Bell","year":"2018","journal-title":"Hum Reprod."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2010-0334","article-title":"Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-m\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism","volume":"95","author":"Dewailly","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1210\/jc.2005-2693","article-title":"Increased anti-M\u00fcllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome","volume":"91","author":"Sir-Petermann","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1210\/jc.2009-1771","article-title":"Effects of birth weight on anti-mullerian hormone serum concentrations in infant girls","volume":"95","author":"Sir-Petermann","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/jc.2009-1849","article-title":"Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/humrep\/des027","article-title":"Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood","volume":"27","author":"Davies","year":"2012","journal-title":"Hum Reprod."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.fertnstert.2019.03.015","article-title":"Children born to women with polycystic ovary syndrome-short- and long-term impacts on health and development","volume":"111","author":"Vanky","year":"2019","journal-title":"Fertil Steril."},{"key":"B85","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1210\/jc.2016-2707","article-title":"Normal pubertal development in daughters of women with PCOS: a controlled study","volume":"102","author":"Legro","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B87","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.tem.2018.09.005","article-title":"Central obesity, faster maturation, and 'PCOS' in girls","volume":"29","author":"De Zegher","year":"2018","journal-title":"Trends Endocrinol Metab."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1210\/jc.2015-3926","article-title":"Evidence for increased 5\u03b1-reductase activity during early childhood in daughters of women with polycystic ovary syndrome","volume":"101","author":"Torchen","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12958-017-0242-9","article-title":"5\u03b1-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Wu","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc."},{"key":"B93","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clindermatol.2017.09.006","article-title":"Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle","volume":"36","author":"Melnik","year":"2018","journal-title":"Clin Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2019","journal-title":"Hum Reprod"},{"key":"B95","doi-asserted-by":"publisher","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/09513590.2014.974535","article-title":"Pregnancy complications in polycystic ovary syndrome patients","volume":"31","author":"Katulski","year":"2015","journal-title":"Gynecol Endocrinol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1530\/EC-18-0076","article-title":"Polycystic ovary syndrome and risk factors for gestational diabetes","volume":"7","author":"Mustaniemi","year":"2018","journal-title":"Endocr Connect."},{"key":"B98","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12916-016-0733-0","article-title":"Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence","volume":"14","author":"Wang","year":"2016","journal-title":"BMC Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e3154","DOI":"10.1002\/dmrr.3154","article-title":"Inositol and antioxidant supplementation: safety and efficacy in pregnancy","volume":"35","author":"Formoso","year":"2019","journal-title":"Diabetes Metab Res Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11154-018-9455-2","article-title":"Impact of pregnancy on inborn errors of metabolism","volume":"19","author":"Wilcox","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00592-019-01397-4","article-title":"Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement","volume":"56","author":"Vitacolonna","year":"2019","journal-title":"Acta Diabetol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1152\/ajpendo.00266.2019","article-title":"Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation","volume":"319","author":"Xu","year":"2019","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1039\/C9FO02919B","article-title":"A pregnancy complication-dependent change in SIgA-targeted microbiota during third trimester","volume":"11","author":"Cui","year":"2020","journal-title":"Food Funct."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0226545","DOI":"10.1371\/journal.pone.0226545","article-title":"The microbiota composition of the offspring of patients with gestational diabetes mellitus (GDM)","volume":"14","author":"Ponzo","year":"2019","journal-title":"PLoS ONE."},{"key":"B105","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3275\/7746","article-title":"Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects","volume":"34","author":"Calogero","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40618-017-0728-5","article-title":"Does a male polycystic ovarian syndrome equivalent exist?","volume":"41","author":"Cannarella","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B107","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","article-title":"Hyperinsulinemia is common in family members of women with polycystic ovary syndrome","volume":"66","author":"Norman","year":"1996","journal-title":"Fertil Steril"},{"key":"B108","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4067\/S0034-98872001000700001","article-title":"Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome","volume":"129","author":"Ben\u00edtez","year":"2001","journal-title":"Rev Med Chil"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"B110","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","article-title":"Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries","volume":"60","author":"Kaushal","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B112","first-page":"129","article-title":"Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS)","volume":"62","author":"Lenarcik","year":"2011","journal-title":"Endokrynologia Polska"},{"key":"B113","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.fertnstert.2016.03.029","article-title":"Increased antimullarian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome","volume":"106","author":"Torchen","year":"2016","journal-title":"Fertil Steril"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/humrep\/deu282","article-title":"Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Hum Reprod"},{"key":"B115","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","article-title":"Patterned loss of hair in man: types and incidence","volume":"53","author":"Hamilton","year":"1951","journal-title":"Ann NY Acad Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South Med J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000293493","article-title":"Familial clustering in the polycystic ovarian syndrome","volume":"28","author":"Lunde","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"B118","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930573","article-title":"What may be the markers of the male equivalent of polycystic ovary syndrome?","volume":"53","author":"Duskov\u00e1","year":"2004","journal-title":"Physiol Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"7801","DOI":"10.1038\/s41598-017-08528-3","article-title":"Glycolipid and hormonal profiles in young men with early-onset androgenetic alopecia: a meta-analysis","volume":"7","author":"Cannarella","year":"2017","journal-title":"Sci Rep"},{"key":"B120","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jama.1993.03500080046030","article-title":"A case-control study of baldness in relation to myocardial infarction in men","volume":"269","author":"Lesko","year":"1993","journal-title":"JAMA"},{"key":"B121","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/archinte.160.2.165","article-title":"Male pattern baldness and coronary heart disease: the physicians' health study","volume":"160","author":"Lotufo","year":"2000","journal-title":"Arch Intern Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/oxfordjournals.aje.a117722","article-title":"Baldness and coronary heart disease rates in men from the framingham study","volume":"142","author":"Herrera","year":"1995","journal-title":"Am J Epidemiol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a008797","article-title":"Baldness and ischemic heart disease in a national sample of men","volume":"143","author":"Ford","year":"1996","journal-title":"Am J Epidemiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ijcard.2014.07.079","article-title":"Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis","volume":"176","author":"Trieu","year":"2014","journal-title":"Int J Cardiol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/jamadermatol.2013.130","article-title":"Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease","volume":"149","author":"Su","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"854e7","DOI":"10.2337\/dc12-1371","article-title":"Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study","volume":"36","author":"D' Anna","year":"2013","journal-title":"Diabetes Care."},{"key":"B127","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/cen.13753","article-title":"Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews","volume":"89","author":"Tay","year":"2018","journal-title":"Clin Endocrinol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.2196\/resprot.9024","article-title":"Comparing the effects of combined oral contraceptives containing progestins with low androgenic and antiandrogenic activities on the hypothalamic-pituitary-gonadal axis in patients with polycystic ovary syndrome: systematic review and meta-analysis","volume":"7","author":"Amiri","year":"2018","journal-title":"JMIR Res Protoc."},{"key":"B129","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jogoh.2019.03.025","article-title":"Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: systematic review and meta-analysis of randomized clinical trials","volume":"48","author":"Menshawy","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod."},{"key":"B130","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2016.05.013","article-title":"Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K\/Akt signaling pathway","volume":"433","author":"Gao","year":"2016","journal-title":"Mol Cell Endocrinol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","author":"Naderpoor","year":"2016","journal-title":"Hum Reprod Update."},{"key":"B132","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4103\/2230-8210.189231","article-title":"The inositols and polycystic ovary syndrome","volume":"20","author":"Bharti","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"B133","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12020-019-01860-w","article-title":"The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis","volume":"64","author":"Wang","year":"2019","journal-title":"Endocrine."},{"key":"B134","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13224-018-1140-6","article-title":"Effect of orlistat versus metformin in various aspects of polycystic ovarian syndrome: a systematic review of randomized control trials","volume":"68","author":"Panda","year":"2018","journal-title":"J Obstet Gynaecol India."},{"key":"B135","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online."},{"key":"B136","doi-asserted-by":"publisher","first-page":"6306410","DOI":"10.1155\/2016\/6306410","article-title":"Metabolism and ovarian function in PCOS women: a therapeutic approach with inositols","volume":"2016","author":"Lagan\u00e0","year":"2016","journal-title":"Int J Endocrinol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie."},{"key":"B138","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/15604280212528","article-title":"D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance","volume":"3","author":"Larner","year":"2002","journal-title":"Int J Exp Diabetes Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/09513590.2015.1054802","article-title":"Reflections on inositol(s) for PCOS therapy: steps toward success","volume":"31","author":"Nestler","year":"2015","journal-title":"Gynecol Endocrinol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","article-title":"Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach","volume":"29","author":"Lagan\u00e0","year":"2018","journal-title":"Trends Endocrinol Metab."},{"key":"B141","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1507\/endocrj.EJ14-0566","article-title":"Myo-inositol: with or without","volume":"62","author":"Carlomagno","year":"2016","journal-title":"Endocrine J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40618-017-0762-3","article-title":"Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index","volume":"41","author":"Condorelli","year":"2018","journal-title":"J Endocrinol Invest."},{"key":"B143","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/09513590.2017.1342240","article-title":"PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution","volume":"33","author":"Condorelli","year":"2017","journal-title":"Gynecol Endocrinol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clnesp.2019.03.015","article-title":"Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: a systematic review and meta-analysis","volume":"32","author":"Rahimlou","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"B145","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2337\/db08-0473","article-title":"Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance","volume":"58","author":"Padmalayam","year":"2009","journal-title":"Diabetes."},{"key":"B146","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clnu.2017.06.002","article-title":"Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials","volume":"37","author":"Namazi","year":"2018","journal-title":"Clin Nutr"},{"key":"B147","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1517\/13543784.16.3.291","article-title":"Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome","volume":"16","author":"Pershadsingh","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"B148","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00228-020-02844-w","article-title":"Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Haghighatdoost","year":"2020","journal-title":"Eur J Clin Pharmacol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1089\/ars.2005.7.1032","article-title":"Utilization of the insuli-signaling network in the metabolic actions of \u03b1-lipoic acid- reduction or oxidation?","volume":"7","author":"Konrad","year":"2005","journal-title":"Antioxid Redox Sign."},{"key":"B150","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fphar.2011.00069","article-title":"Diabetes and alpha lipoic acid","volume":"2","author":"Golbidi","year":"2011","journal-title":"Front Pharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e13153","DOI":"10.1111\/aji.13153","article-title":"Effect of alpha-lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women","volume":"82","author":"Di Nicuolo","year":"2019","journal-title":"Am J Reprod Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/09513590.2015.1014784","article-title":"D-chiro-inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS","volume":"31","author":"Cianci","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/193229681000400218","article-title":"Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome","volume":"4","author":"Masharani","year":"2010","journal-title":"J Diabetes Sci Technol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/09513590.2017.1313972","article-title":"Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action","volume":"33","author":"De Cicco","year":"2017","journal-title":"Gynecol Endocrinol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2161-1017.1000140","article-title":"Effects of a combination of alpha lipoic acid and myo-inoitol on insulin dynamics in overweight\/obese patients with PCOS","volume":"3","author":"Gennazzani","year":"2014","journal-title":"Endocrinol Metab Synd"},{"key":"B156","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-017-0782-z","article-title":"Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients","volume":"41","author":"Genazzani","year":"2018","journal-title":"J Endocrinol Invest."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00404-013-2855-3","article-title":"The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial","volume":"288","author":"Colazingari","year":"2013","journal-title":"Arch Gynecol Obstet."},{"key":"B158","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub5","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","article-title":"Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil Steril."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmatic sperm injection cycles","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertil Steril."},{"key":"B161","first-page":"509","article-title":"Effects of myoinositol supplementation on oocyte's quality in PCOS patients: a double blind trial","volume":"15","author":"Ciotta","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/humrep\/dex330","article-title":"Antioxidants improve IVF outcome and subsequent embryo development in the mouse","volume":"32","author":"Truong","year":"2017","journal-title":"Hum Reprod."},{"key":"B163","first-page":"913","article-title":"Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study","volume":"29","author":"Rago","year":"2015","journal-title":"J Biol Regul Homeost Agents."},{"key":"B164","first-page":"429","article-title":"Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease","volume":"63","author":"Ciotta","year":"2011","journal-title":"Minerva Ginecol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/oby.21651","article-title":"Hepatic steatosis is common in adolescents with obesity and PCOS and relates to de novo lipogenesis but not insulin resistance","volume":"24","author":"Cree-Green","year":"2016","journal-title":"Obesity."},{"key":"B166","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/ijmm.2019.4234","article-title":"Excess fructose and fatty acids trigger a model of non alcoholic fatty liver disease progression in vitro: protective effect of the flavonoid silybin","volume":"44","author":"Grasselli","year":"2019","journal-title":"Int J Mol Med."},{"key":"B167","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1038\/s41598-019-40105-8","article-title":"Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures","volume":"9","author":"Lama","year":"2019","journal-title":"Sci Rep."},{"key":"B168","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnut.2017.00042","article-title":"The nutraceutic Silybin counteracts excess lipid accumulation and ongoing oxidative stress in an in vitro model of non-alcoholic fatty liver disease progression","volume":"4","author":"Vecchione","year":"2017","journal-title":"Front Nutr."},{"key":"B169","doi-asserted-by":"publisher","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the effect derived from silybin with vitamin d and vitamin e administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and serological worsening markers in nonalcoholic fatty liver disease patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxid Med Cell Longev."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e0173373","DOI":"10.1371\/journal.pone.0173373","article-title":"Resveratrol ameliorates the chemical and microbial induction of inflammation and IR in human placenta, adipose tissue and skeletal muscle","volume":"12","author":"Tran","year":"2017","journal-title":"PLoS ONE."},{"key":"B171","first-page":"17","article-title":"Evaluation of plasma homocysteine levels in patients of PCOS","volume":"66","author":"Diwaker","year":"2018","journal-title":"J Assoc Physicians India"},{"key":"B172","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1476-511X-10-193","article-title":"Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystic ovary syndrome","volume":"10","author":"Karadeniz","year":"2011","journal-title":"Lipids Health Dis."},{"key":"B173","first-page":"25","article-title":"Correlation between levels of homocysteine, anti-m\u00fcllerian hormone and insulin resistance in PCOS patients with recurrent miscarriage","volume":"290","author":"Asanidze","year":"2019","journal-title":"Georgian Med News."},{"key":"B174","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13098-019-0484-0","article-title":"Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome","volume":"11","author":"Piazzolla","year":"2019","journal-title":"Diabetol Metab Syndr."},{"key":"B175","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/bab.1799","article-title":"Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension","volume":"66","author":"Singh","year":"2019","journal-title":"Biotechnol Appl Biochem."},{"key":"B176","doi-asserted-by":"publisher","first-page":"e006278","DOI":"10.1161\/JAHA.117.006278","article-title":"Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20 000 patients","volume":"6","author":"Totzeck","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B177","doi-asserted-by":"publisher","first-page":"CD010443","DOI":"10.1002\/14651858.CD010443.pub3","article-title":"Combined diet and exercise interventions for preventing gestational diabetes mellitus","volume":"2017","author":"Shepherd","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B178","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B179","doi-asserted-by":"publisher","first-page":"CD012378","DOI":"10.1002\/14651858.CD012378.pub2","article-title":"Inositol for subfertile women with polycystic ovary syndrome","volume":"2018","author":"Showell","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B180","doi-asserted-by":"publisher","first-page":"503.e1","DOI":"10.1016\/j.ajog.2016.05.038","article-title":"The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity","volume":"215","author":"Ferrari","year":"2016","journal-title":"Am J Obstet Gynecol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11892-016-0726-6","article-title":"Myo-inositol supplementation to prevent gestational diabetes mellitus","volume":"16","author":"Celentano","year":"2016","journal-title":"Curr Diab Rep."},{"key":"B182","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/09513590.2011.633665","article-title":"Myo-inositol may prevent gestational diabetes in PCOS women","volume":"28","author":"D'Anna","year":"2012","journal-title":"Gynecol Endocrinol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/nu11020330","article-title":"Diet-Gut microbiota interactions and gestational diabetes mellitus (GDM)","volume":"11","author":"Ponzo","year":"2019","journal-title":"Nutrients."},{"key":"B184","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4162\/nrp.2011.5.2.107","article-title":"Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus","volume":"5","author":"Kim","year":"2011","journal-title":"Nutr Res Pract."},{"key":"B185","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4274\/jtgga.2018.0077","article-title":"The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: a critical review","volume":"19","author":"G\u00fcnalan","year":"2018","journal-title":"J Turk Ger Gynecol Assoc."},{"key":"B186","doi-asserted-by":"publisher","first-page":"5364730","DOI":"10.1155\/2019\/5364730","article-title":"Effects of probiotic supplement in pregnant women with gestational diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"2019","author":"Zhang","year":"2019","journal-title":"J Diabetes Res."},{"key":"B187","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.7417\/T.2017.2013","article-title":"Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients?","volume":"168","author":"Malvasi","year":"2017","journal-title":"Clin Ter."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:30:34Z","timestamp":1696505434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":187,"alternative-id":["10.3389\/fendo.2020.00516"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00516","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"516"}}